Language Select


Recent News
Aug 14, 2017

Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy and radiosurgery systems and software, will hold a meeting for investors on Tuesday, Sept. 26, 2017, at the annual meeting of...

Aug 10, 2017

Varian Medical Systems (NYSE: VAR) today announced it has named J. Michael Bruff as Vice President of Investor Relations effective August 7, 2017. Mr. Bruff, 48, replaced Spencer Sias who retired...

Aug 9, 2017

Varian Medical Systems (NYSE: VAR) today announced it has signed an agreement with Bionix® Radiation Therapy to distribute Bionix brachytherapy applicators. Varian will market the Bionix...

More news >

Recent Blog Posts
Aug 17, 2017Centerline
Multidisciplinary tumor boards are important for the continuity of care and improved patient outcomes. Maximizing the effectiveness of tumor boards is one reason Cone Health is implementing the Multidisciplinary Tumor Board module of the Varian 360 Oncology™ care management platform.
Read more
Aug 17, 2017Spot ON
The Alliance for Proton Therapy Access (the Alliance) is an advocacy organization working to make sure all cancer patients seeking proton therapy receive fair and timely payment decisions from their health insurers.
Read more
Aug 16, 2017Centerline
Varian’s RapidPlan™ knowledge-based planning is helping clinicians at centers around the world take treatment planning to new levels of consistency, efficiency, and quality.
Read more
Corporate Communications Contacts
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.